Green Cross Holdings (005250)

Currency in KRW
9,580
-170(-1.74%)
Closed·
Advertisement
005250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,5409,890
52 wk Range
8,63018,010
Key Statistics
Bid/Ask
9,540.00 / 9,560.00
Prev. Close
9,750
Open
9,700
Day's Range
9,540-9,890
52 wk Range
8,630-18,010
Volume
53.93K
Average Volume (3m)
86.34K
1-Year Change
-38.1536%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
005250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
14/08/2026
EPS / Forecast
34.00 / --
Revenue / Forecast
596.27B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -2,698.71%
Dividend Yield
3.08%
Industry Median 1.22%
Annualised payout
300.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 005250 to Peers and Sector

Metrics to compare
005250
Peers
Sector
Relationship
P/E Ratio
−3.6x−1.0x−0.3x
PEG Ratio
0.020.090.00
Price/Book
0.5x1.7x2.6x
Price / LTM Sales
0.2x3.9x3.0x
Upside (Analyst Target)
-46.9%59.8%
Fair Value Upside
Unlock17.5%7.1%Unlock

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille’s syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Additionally, the company provides personalized nutrition injections. The company was formerly known as Green Cross Holdings Corporation and changed its name to GC Corp. in April 2026. The company was founded in 1967 and is headquartered in Yongin-Si, South Korea.

Employees
142

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.41M3.09%13.71B
Other Institutional Investors
13.10M28.83%127.73B
Public Companies & Retail Investors
30.93M68.08%301.61B
Total
45.44M100.00%443.05B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MOGAM Biotechnology Research Institute9.03%4,102,19039,996,353
National Pension Service6.55%2,976,06229,016,605

People Also Watch

73,800
103590
-9.34%
5,820
025860
-2.02%
31,250
108670
-2.50%
43,700
005090
-4.69%
902
020760
0.00%

FAQ

What Is the Green Cross Holdings (Seoul: 005250) Share Price Today?

The Green Cross Holdings stock price today is 9,580 KRW.

What Stock Exchange Does Green Cross Holdings (005250) Trade On?

Green Cross Holdings is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Green Cross Holdings?

The stock symbol (also called a 'ticker') for Green Cross Holdings is "005250."

Does Green Cross Holdings Pay Dividends? What’s The Current 005250 Dividend Yield?

Yes, 005250 Pays Dividends to its Shareholders. The current Green Cross Holdings dividend yield is 3.08%.

What Is the Current Green Cross Holdings Market Capitalisation?

As of today, Green Cross Holdings (Seoul: 005250) market cap is 445.04B KRW.

What Is Green Cross Holdings's (005250) Earnings Per Share (TTM)?

The Green Cross Holdings EPS is currently -2,699 (Trailing Twelve Months).

When Is the Next Green Cross Holdings Earnings Date?

Green Cross Holdings's next earnings report will be released on 18/11/2026.

Is 005250 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Green Cross Holdings moving averages and other technical indicators, the daily buy/sell signal for 005250 stock is Sell.

How Many Times Has Green Cross Holdings Stock Split?

Green Cross Holdings has split 9 times. (See the 005250 stock split history page for full effective split date and price information.)

How Many Employees Does Green Cross Holdings Have?

Green Cross Holdings has 142 employees, based on their latest Companies House report.

What is the current trading status of Green Cross Holdings (Seoul: 005250)?

As of 12/10/2026, Green Cross Holdings (005250) is trading at a share price of 9,580 KRW, with a previous close of 9,750 KRW. The stock has fluctuated within a day range of 9,540 KRW to 9,890 KRW, while its 52-week range spans from 8,630 KRW to 18,010 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.